153
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Anti-β2-glycoprotein I paratopes and β2-glycoprotein I epitopes characterization using random peptide libraries

, , , &
Pages 438-444 | Received 20 Feb 2014, Accepted 08 Apr 2014, Published online: 12 May 2014

References

  • Dani, M. 2001. Peptide display libraries: design and construction. J. Recept. Signal. Transduct. Res. 21: 469–488
  • Bottger, V., and A. Bottger. 2009. Epitope mapping using phage display peptide libraries. Methods Mol. Biol. 524: 181–201
  • Dani, M. 2001. Biological libraries. J. Recept. Signal. Transduct. Res. 21: 447–468
  • Atsumi, T., O. Amengual, S. Yasuda, et al. 2005. Research around beta 2-glycoprotein I: a major target for antiphospholipid antibodies. Autoimmunity. 38: 377–381
  • Tincani, A., G. Balestrieri, E. Danieli, et al. 2003. Pregnancy complications of the antiphospholipid syndrome. Autoimmunity. 36: 27–32
  • Blank, M., D. Faden, A. Tincani, et al. 1994. Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice. J. Autoimmun. 7: 441–455
  • Danowski, A., T. S. Kickler, and M. Petri. 2006. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus. J. Rheumatol. 33: 1775–1779
  • Tincani, A., C. Casu, S. Cartella, et al. 2010. Antiphospholipid antibody: laboratory, pathogenesis and clinical manifestations. Reumatismo. 62: 65–75
  • Alijotas-Reig, J., R. Ferrer-Oliveras, M. J. Rodrigo-Anoro, et al. 2010. Anti-beta(2)-glycoprotein-I and anti-phosphatidylserine antibodies in women with spontaneous pregnancy loss. Fertil. Steril. 93: 2330–2336
  • Cucnik, S., T. Kveder, Z. Ulcova-Gallova, et al. 2011. The avidity of anti-beta2-glycoprotein I antibodies in patients with or without antiphospholipid syndrome: a collaborative study in the frame of the European forum on antiphospholipid antibodies. Lupus. 20: 1166–1171
  • Zager, U., S. Irman, M. Lunder, et al. 2011. Immunochemical properties and pathological relevance of anti-beta(2)-glycoprotein I antibodies of different avidity. Int. Immunol. 23: 511–518
  • Cucnik, S., T. Kveder, I. Krizaj, et al. 2004. High avidity anti-beta 2-glycoprotein I antibodies in patients with antiphospholipid syndrome. Ann. Rheum. Dis. 63: 1478–1482
  • Cucnik, S., I. Krizaj, B. Rozman, et al. 2004. Concomitant isolation of protein C inhibitor and unnicked beta2-glycoprotein I. Clin. Chem. Lab. Med. 42: 171–174
  • Cucnik, S., A. Ambrozic, B. Bozic, et al. 2000. Anti-beta2-glycoprotein I ELISA: methodology, determination of cut-off values in 434 healthy Caucasians and evaluation of monoclonal antibodies as possible international standards. Clin. Chem. Lab. Med. 38: 777–783
  • Mayrose, I., O. Penn, E. Erez, et al. 2007. Pepitope: epitope mapping from affinity-selected peptides. Bioinformatics. 23: 3244–3246
  • Marai, I., A. Tincani, G. Balestrieri, and Y. Shoenfeld. 2005. Anticardiolipin and anti-beta-2-glycoprotein I antibodies. Autoimmunity. 38: 33–38
  • Ioannou, Y., C. Pericleous, I. Giles, et al. 2007. Binding of antiphospholipid antibodies to discontinuous epitopes on domain I of human beta(2)-glycoprotein I: mutation studies including residues R39 to R43. Arthritis Rheum. 56: 280–290
  • Inanc, M., E. L. Radway-Bright, and D. A. Isenberg. 1997. beta 2-Glycoprotein I and anti-beta 2-glycoprotein I antibodies: where are we now? Br. J. Rheumatol. 36: 1247–1257
  • Ichikawa, K., A. Tsutsumi, T. Atsumi, et al. 1999. A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies. Arthritis Rheum. 42: 2461–2470
  • Castel, G., M. Chteoui, B. Heyd, and N. Tordo. 2011. Phage display of combinatorial peptide libraries: application to antiviral research. Molecules. 16: 3499–3518
  • Jurgec, I., M. Lunder, T. Bratkovic, et al. 2009. Hydrogen bonds are crucial for the anti-beta 2-glycoprotein I antibody bindings to the antigen. In European Workshop for Rheumatology Research. T.K. Kvien, ed. BMJ Publ. Group, Warsaw–Poland. p. A4
  • Giles, I., A. Lambrianides, and A. Rahman. 2008. Examining the non-linear relationship between monoclonal antiphospholipid antibody sequence, structure and function. Lupus. 17: 895–903
  • Blank, M., Y. Shoenfeld, S. Cabilly, et al. 1999. Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides. Proc. Natl. Acad. Sci. USA. 96: 5164–5168
  • Janeway, C. 2005. Immunobiology: the Immune System in Health and Disease. New York: Garland Science
  • Lo, B. K. 2004. Antibody Engineering: Methods and Protocols. Totowa, NJ: Humana Press
  • Bottger, V. 2001. Epitope Mapping with Random Peptide Libraries. Heidelberg: Springer Verlag
  • Agar, C., G. M. van Os, M. Morgelin, et al. 2010. Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome. Blood. 116: 1336–1343
  • Kasahara, H., E. Matsuura, K. Kaihara, et al. 2005. Antigenic structures recognized by anti-beta2-glycoprotein I auto-antibodies. Int. Immunol. 17: 1533–1542
  • Lieberman, M. A. 2006. Marks' Basic Medical Biochemistry: a Clinical Approach. Philadelphia, PA: Lippincott Williams & Wilkins
  • Elgert, K. D. 2009. Immunology: Understanding the Immune System. Hoboken, NJ: Wiley-Blackwell

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.